Life Sciences
Life Sciences: The Latest
  • EU Highlights
  • Viewpoints

Irish national Pierre Meulien appointed to run Innovative Medicines Initiative

The current head of Genome Canada will take over as executive director of the world’s largest pharmaceuticals public-private partnership in September

Europe’s biotech companies unite to fight antimicrobial resistance

The BEAM Alliance – Biotechs from Europe innovating in Antimicrobial Resistance - brings together 37 companies from ten countries to accelerate progress in dealing with drug-resistant infections

Pharma industry hits out at Horizon 2020 cut

Europe’s pharma industry says the €2.2B cut to Horizon 2020 is misguided, while scientists and MEPs declare themselves happy, for the most part, that the cut is less than the €2.7B originally proposed

Patents can make or break drug discovery in Poland

There are several barriers holding back science-industry collaboration, but the most urgent one is the reluctance to protect intellectual property in advance of publishing research results, according to two of Poland’s leading patent attorneys

Patients should have more control over their health

Smartphones can help you understand and look after your health says Bruce Hellman, chief executive of health app start-up uMotif

Our research saves lives – if you let us

A new EU data protection law risks killing some types of medical research, researchers at the Karolinska Institutet say. Their prescription: A law that regulates Big Data, but allows for research

Life Sciences Archive
Karolinska Institutet: Artificial neuron mimics function of human cells
Scientists at Sweden’s Karolinska Institutet have managed to build a fully functional neuron by using organic bioelectronics. This artificial neuron contain...
Irish national Pierre Meulien appointed to run Innovative Medicines Initiative
The current head of Genome Canada will take over as executive director of the world’s largest pharmaceuticals public-private partnership in September...
Europe’s biotech companies unite to fight antimicrobial resistance
The BEAM Alliance – Biotechs from Europe innovating in Antimicrobial Resistance - brings together 37 companies from ten countries to accelerate...
Pharma industry hits out at Horizon 2020 cut
Europe’s pharma industry says the €2.2B cut to Horizon 2020 is misguided, while scientists and MEPs declare themselves happy, for the...
Patents can make or break drug discovery in Poland
There are several barriers holding back science-industry collaboration, but the most urgent one is the reluctance to protect intellectual property in...
Page 1 of 684> 1 2 3  ... 
Innovation in Progress - Science|Business Network

Karolinska Institutet: Artificial neuron mimics function of human cells

Scientists at Sweden’s Karolinska Institutet have managed to build a fully functional neuron by using organic bioelectronics. This artificial neuron contain no ‘living’ parts, but is capable of mimicking the function of a human nerve cell and communicate in the same way as our own neurons do.

Aalto University researcher receives ERC Consolidator Grant

The project aims to accelerate benefits of the genomic era, by finding novel proteins and enzymes with totally new and useful properties.

Imperial researchers win Health Foundation grant for cancer innovation study

A research team from Imperial College Business School has been chosen by the Health Foundation to be part of its £1.5 million Efficiency Research Programme. The award is for original research on system efficiency and value for money in health and social care.

Horizon 2020 Special Coverage
Unlocking the value of Personalised Healthcare in Europe
This new study shows ICT investments could cut healthcare costs for key ailments by more than 35%.
Bigger and Simpler: A short guide to the EU's €80 billion Horizon 2020 programme
A two-year political fight formally began in Brussels on 30 November with the publication of the European Commission's plan for Horizon 2020, its omnibus R&D programme. It promises less red tape, broader benefits, and more jobs and economic growth.
Biofuels: The Next Generation
Key ideas and recommendations to accelerate the deployment of sustainable biofuels have emerged at the second in a series of three high-level academic policy debates on the energy R&D challenge, The Energy Difference
Advertisement